Inside EU Health Inside EU Health: AZ warns Germany; fair pricing savings €27 B; safe heart screening AstraZeneca warns German reforms could push pharma launches and investment out of Europe; fair pricing model highlights €27 billion of potential savings in Europe; Commission launches consultation on screening for cardiovascular diseases
Inside EU Health Inside EU Health: Biotech Act; targeted fix of medical devices; ‘Safe Hearts Plan’ arrives 🎄Happy Christmas! The Health Package has arrived: Biotech Act, Targeted fix of medical device and; ‘Safe Hearts Plan’
Cardiovascular disease ‘Safe Hearts Plan’ sets out an EU response, but critics see gaps Critics warn that the EU’s cardiovascular disease plan lacks the strong preventive measures needed to match the scale of the problem
Cardiovascular disease Cardiovascular disease is estimated to cost the EU 2% of GDP Ahead of tomorrow’s ‘Safe Hearts Plan’ on cardiovascular disease, the Commission released a report which shows the heavy toll on Europe’s health and its pockets
